Effects of ulinastatin on hepatorenal function and cellular immunity in patients undergoing thoracic surgery

SHEN Yaofeng,XU Meiying
DOI: https://doi.org/10.3969/j.issn.0253-9934.2005.11.008
2005-01-01
Abstract:Objective To investigate the effects of ulinastain (UTI) on hepatorenal function and cellular immunity in patients undergoing thoracic surgery. Methods 32 patients with normal preoperative hepatorenal function were randomly divided into two groups: UTI group (16 cases) in which the patients received UTI 10 000 U/kg, and control group (16 cases) without UTI infusion. Blood samples were collected from peripheral vein for the measurements of ALT, BUN, Cr and T cell subset (CD3~+, CD4~+, CD8~+, CD4~+/CD8~+) at 3 time points: before operation, 2 and 7 d after operation. Results Comparing with the control group, ALT, BUN and Cr of UTI group decreased significantly 2 d after the operation. In both groups, comparing with the baseline values (before operation), CD3~+, CD4~+, CD4~+/CD8~+ decreased and CD8~+ increased 2 d after the operation. On 7 d postoperatively, comparing with the control group, CD3~+, CD4~+, CD4~+/CD8~+ of UTI group increased and CD8~+ decreased. Conclusion Ulinastain (10 000 U/kg) can promote cellular immunity and protect the hepatorenal function.
What problem does this paper attempt to address?